Related Experiment Video
Updated: Mar 31, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
[CARDIOVASCULAR DISEASES AS A RISK FACTOR OF CHRONIC GLOMERULONEPHRITIS PROGRESS]
Insights
Chronic glomerulonephritis (CGN) with cardiovascular diseases (CVD) significantly worsens kidney function and reduces survival rates. This combination negatively impacts liver function and patient outcomes before dialysis.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Context:
- Cardiovascular diseases (CVD) frequently coexist with chronic glomerulonephritis (CGN).
- Understanding the impact of CVD on CGN progression is crucial for patient management.
- The study investigated the clinical course and outcomes of CGN patients with and without CVD.
Purpose:
- To evaluate the effect of concomitant cardiovascular diseases (CVD) on the progression of chronic glomerulonephritis (CGN).
- To compare renal function and survival rates in CGN patients with and without CVD.
- To assess the impact of combined CGN and CVD on liver function and survival.
Summary:
- Patients with CGN and concurrent CVD exhibited significantly higher serum creatinine levels and reduced glomerular filtration rates compared to those with CGN alone.
- The presence of CVD in CGN patients led to a significant decrease in 5- and 7-year survival rates.
- Combined CGN and CVD negatively affected nitrogen excretion and reduced liver survival rates in the pre-dialysis stage.
Impact:
- Highlights the detrimental effect of cardiovascular comorbidities on chronic kidney disease progression.
- Emphasizes the need for integrated management of CGN and CVD to improve patient prognosis.
- Suggests that early detection and treatment of CVD in CGN patients may mitigate adverse outcomes and improve survival.
Unlabelled:
The study was aimed at studying progression of chronic glomerulonephritis (CGN) associated with cardiovascular diseases (CVD).
Materials And Methods:
The clinical course of CGN with and without concomitant CVD was followed up in 75 men and 44 women aged 17-66 (mean 37.6 ± 12.9) years. Duration of the disease varied from 1 to 17 years. The appearance of persistent proteinuria and/or hematuria was regarded as the onset of the disease. The following laboratory parameters were recorded: hemoglobin level, packed cell volume, erythrocyte number daily proteinuria, glomerular filtration rate. CVD were diagnosed using electro- and echocardiography, veloergometry, and 24 hr Holter monitoring.
Results:
Patients with CGN and CVD showed a significantly increased serum creatinine level] 110 (180-181) vs 87 (64-134) mcmol/l, p = 0.01], reduced glomerular filtration rate [79.1 (41.1-104.5) vs 103.1 (67.2-146.8) ml/min, p = 0.0I] compared to the patients with CGN without CVD. Combination of CGN and CVD significantly decreased the 5 and 7 year survival rate.
Conclusion:
Combination of CGN and SVD at the pre-dialysis stage deteriorates nitrogen excretion by the liver and reduces the liver survival rate.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome I : Introduction

